(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-3.32%) $1.920
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
2.26% ¥ 2 467.50
Live Chart Being Loaded With Signals
Medipal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. It procures healthcare products related to diagnostics, testing, treatment, and administration comprises medical equipment and medical materials, and clinical diagnostic reagents for use from the pre-symptomatic stage; handles PMS services on contract for manufacturers; and invests in orphan drugs and other products...
Stats | |
---|---|
Объем за сегодня | 794 000 |
Средний объем | 621 219 |
Рыночная капитализация | 518.22B |
EPS | ¥0 ( 2024-02-04 ) |
Дата следующего отчета о доходах | ( ¥41.18 ) 2024-05-13 |
Last Dividend | ¥23.00 ( 2023-03-30 ) |
Next Dividend | ¥0 ( N/A ) |
P/E | 14.03 |
ATR14 | ¥1.725 (0.07%) |
Объем Корреляция
MediPal Holdings Корреляция
10 Самые положительные корреляции |
---|
10 Самые отрицательные корреляции |
---|
Вы знали?
Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).
Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.
MediPal Holdings Корреляция - Валюта/Сырье
MediPal Holdings Финансовые показатели
Annual | 2022 |
Выручка: | ¥3 360.01B |
Валовая прибыль: | ¥224.31B (6.68 %) |
EPS: | ¥184.82 |
FY | 2022 |
Выручка: | ¥3 360.01B |
Валовая прибыль: | ¥224.31B (6.68 %) |
EPS: | ¥184.82 |
FY | 2022 |
Выручка: | ¥3 290.92B |
Валовая прибыль: | ¥217.45B (6.61 %) |
EPS: | ¥140.14 |
FY | 2021 |
Выручка: | ¥3 211.17B |
Валовая прибыль: | ¥214.26B (6.67 %) |
EPS: | ¥113.96 |
Financial Reports:
No articles found.
MediPal Holdings Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
¥23.00 (N/A) |
¥0 (N/A) |
¥23.00 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | ¥6.00 | 2001-03-27 |
Last Dividend | ¥23.00 | 2023-03-30 |
Next Dividend | ¥0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 46 | -- |
Total Paid Out | ¥539.00 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.98 | -- |
Div. Sustainability Score | 5.56 | |
Div.Growth Potential Score | 4.59 | |
Div. Directional Score | 5.08 | -- |
Year | Amount | Yield |
---|
With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
8058.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
7315.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
6564.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
5915.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
4578.T | Ex Dividend Knight | 2023-12-28 | Semi-Annually | 0 | 0.00% | |
3834.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
3085.T | Ex Dividend Knight | 2023-06-29 | Semi-Annually | 0 | 0.00% | |
1951.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
9507.T | Ex Dividend Junior | 2023-09-28 | Annually | 0 | 0.00% | |
8395.T | Ex Dividend Junior | 2023-09-28 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0106 | 1.500 | 9.79 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0199 | 1.200 | 9.34 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0646 | 1.500 | -0.393 | -0.590 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 1.198 | 0.800 | 9.01 | 7.21 | [1 - 3] |
quickRatioTTM | 0.928 | 0.800 | 9.25 | 7.40 | [0.8 - 2.5] |
cashRatioTTM | 0.194 | 1.500 | -0.0355 | -0.0533 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | 2 432.80 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 259.54 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 259.54 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.0685 | 1.000 | -2.19 | -2.19 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0139 | 1.000 | -1.723 | -1.723 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 1.872 | 0.800 | 0.854 | 0.683 | [0.5 - 2] |
Total Score | 5.56 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 13.97 | 1.000 | 8.69 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0646 | 2.50 | -0.253 | -0.590 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 259.54 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 2.43 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 259.54 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.608 | 1.500 | 9.28 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0156 | 1.000 | -2.11 | 0 | [0.1 - 0.5] |
Total Score | 4.59 |
MediPal Holdings
Medipal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. It procures healthcare products related to diagnostics, testing, treatment, and administration comprises medical equipment and medical materials, and clinical diagnostic reagents for use from the pre-symptomatic stage; handles PMS services on contract for manufacturers; and invests in orphan drugs and other products. The company is also involved in the wholesale of cosmetics, daily necessities, and OTC pharmaceuticals; animal health products for companion animals; food processing raw materials for agriculture, fisheries, and livestock; and livestock feed additives, seasonings, veterinary medical equipment, packaging materials, industrial chemicals, and other products. In addition, it engages in the contract-based epidemiological studies, clinical studies, etc.; creation of a computerized medical supply database and master product databases for medical facilities; health insurance claims reviews, medical coding dispatch, outsourcing, and remote education activities; life and non-life insurance agency business; cleaning management; management and operation of distribution centers; commissioned delivery and worker dispatch business; and planning, management, administration, and product and service development for the class A health dispensing pharmacies service brand. Medipal Holdings Corporation serves hospitals, clinics, dispensing pharmacies, drugstores, home centers, convenience stores, supermarkets, discount stores, animal hospitals, livestock and fishery businesses, and processed food manufacturers. The company was formerly known as Mediceo Paltac Holdings Co., Ltd. and changed its name to Medipal Holdings Corporation in October 2009. Medipal Holdings Corporation was founded in 1898 and is headquartered in Tokyo, Japan.
О Торговые сигналы
Данные торговые сигналы, представленные на этой странице, помогают определить, когда следует ПОКУПАТЬ или ПРОДАВАТЬ NA. Сигналы имеют задержку более 1 минуты. Пожалуйста, примите во внимание, что существует вероятность ошибки или неточностей в силу различных микро и макро факторов влияющих на фондовые рынки.
Данные тор“о”ые сигна“ы не являются определен“ыми, и getagraph.com не несет ответственности за какие-либо действия, предпринятые в от“ошении этих сигналов, как описано в Terms of Use. Сигналы основаны на широком спектре индикаторов технического анализа